Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the quarter, the company announced sales was CNY 230.179 million compared to CNY 288.795 million a year ago. Operating income was CNY 564.227 million compared to CNY 39.820 million a year ago. Net income was CNY 563.299 million compared to CNY 31.989 million a year ago. Basic earnings per share from continuing operations was CNY 1.78 compared to CNY 0.1 a year ago.